EMYRIA LIMITED — Director's Dealing 2023

Oct 9, 2023

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Emyria Limited

ACN 625 085 734

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Stewart Washer
Date of last notice	10 August 2023

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	Dr Stewart James Washer & Dr Patrizia Derna Washer - Dr Washer is a trustee and beneficiary of the superannuation fund Dr Stewart James Washer & Dr Patrizia Derna Washer - trustee and beneficiary of the Trust
Date of change	5 October 2023

No. of securities held prior to change	Dr Stewart James Washer & Dr Patrizia Derna Washer -trustee and beneficiary of the superannuation fund • 1,550,599 fully paid ordinary shares. Dr Stewart James Washer & Dr Patrizia Derna Washer -trustee and beneficiary of the Trust • 28,400,000 fully paid ordinary shares. Mal Washer Nominees Pty Ltd a trustee and beneficiary of the trust • 19,933,333 fully paid ordinary shares. • 166,667 unlisted Options exercisable at $0.35 on or before 22 November 2025.
Class	Fully paid ordinary shares. Unlisted Options exercisable at $0.12 each on or before 5 October 2026.
Number acquired	1,333,333 fully paid ordinary shares. 666,666 unlisted Options exercisable at $0.12 each on or before 5 October 2026.
Number disposed	Nil
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	$0.075 per share and nil per free attaching option.
No. of securities held after change	Dr Stewart James Washer & Dr Patrizia Derna Washer -trustee and beneficiary of the superannuation fund • 1,757,346 fully paid ordinary shares. • 103,373 unlisted Options exercisable at $0.12 each on or before 5 October 2026. Dr Stewart James Washer & Dr Patrizia Derna Washer -trustee and beneficiary of the Trust • 29,526,586 fully paid ordinary shares. • 563,293 unlisted Options exercisable at $0.12 each on or before 5 October 2026. Mal Washer Nominees Pty Ltd a trustee and beneficiary of the trust • 19,933,333 fully paid ordinary shares. • 166,667 unlisted Options exercisable at $0.35 on or before 22 November 2025.

Nature of change

Nature of change Participation in the non-renounceable pro rata entitlement offer to Example: on-market trade, off-market trade, eligible shareholders announced on 4 September 2023, which exercise of options, issue of securities under dividend reinvestment plan, participation in closed on 28 September 2023. buy-back

Part 2 – Change of director’s interests in contracts – N/A

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

thispart.
Detail of contract	N/A
Nature of interest	N/A
Name of registered holder (if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	N/A
Interest after change	N/A

Part 3 –[+] Closed period

Were the interests in the securities or No contracts detailed above traded during a + closed period where prior written clearance was required? If so, was prior written clearance provided to N/A allow the trade to proceed during this period? If prior written clearance was provided, on N/A what date was this provided?

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Emyria Limited

ACN 625 085 734

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Dr Michael Winlo
Date of last notice	9 August 2023

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	-
Date of change	5 October 2023
No. of securities held prior to change	Michael Gordon Winlo • 482,222 fully paid ordinary shares. • 111,111 unlisted Options exercisable at $0.35 on or before 22 November 2025. • Michael Gordon Winlo - trustee and beneficiary of the account • 4,000,000 unlisted Options exercisable at $0.114 each on or before 13 November 2024. • 3,000,000 unlisted Options exercisable at $0.296 each on or before 23 November 2026.
Class	Fully paid ordinary shares. Unlisted Options exercisable at $0.12 each on or before 5 October 2026.

Number acquired	64,297 fully paid ordinary shares. 32,148 unlisted Options exercisable at $0.12 each on or before 5 October 2026.
Number disposed	Nil
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	$0.075 per share and nil per free attaching option.
No. of securities held after change	Michael Gordon Winlo • 546,519 fully paid ordinary shares. • 111,111 unlisted Options exercisable at $0.35 on or before 22 November 2025. • 32,148 unlisted Options exercisable at $0.12 each on or before 5 October 2026. • Michael Gordon Winlo - trustee and beneficiary of the account • 4,000,000 unlisted Options exercisable at $0.114 each on or before 13 November 2024. • 3,000,000 unlisted Options exercisable at $0.296 each on or before 23 November 2026.
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	Participation in the non-renounceable pro rata entitlement offer to eligible shareholders announced on 4 September 2023, which closed on 28 September 2023.

Part 2 – Change of director’s interests in contracts – N/A

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder (if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	N/A
Interest after change	N/A

Part 3 –[+] Closed period

art 3 –+Closed period
Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Emyria Limited

ACN 625 085 734

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Alistair Vickery

Date of last notice 11 August 2023

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct and indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	Netwealth Investments Limited - member and beneficiary of managed super fund
Date of change	5 October 2023

No. of securities held prior to change	Alistair William Vickery • 138,889 fully paid ordinary shares. • 69,444 Unlisted Options exercisable at $0.35 on or before 22 November 2025. Netwealth Investments Limited - member of the managed super fund • 243,418 fully paid ordinary shares. Cherylyn Vickery -*beneficiary of the Trust • 2,000,000 Unlisted Options exercisable at $0.114 on or before 13 November 2024. Note - 115,418 fully paid ordinary shares were acquired by Netwealth Investments Limited at $0.094 per share on 9 August 2023 (refer Appendix 3Y lodged on 11 August 2023) not by Dr Vickery directly. The acquiring entity was disclosed incorrectly due to a miscommunication between Dr Vickery and his broker – all other details on the Appendix 3Y lodged on 11 August 2023 remain correct.
Class	Fully paid ordinary shares. Unlisted Options exercisable at $0.12 each on or before 5 October 2026.
Number acquired	50,975 fully paid ordinary shares. 25,488 unlisted Options exercisable at $0.12 each on or before 5 October 2026.
Number disposed	Nil
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	$0.075 per share and nil per free attaching option.
No. of securities held after change	Alistair William Vickery • 157,408 fully paid ordinary shares. • 69,444 Unlisted Options exercisable at $0.35 on or before 22 November 2025. • 9,260 Unlisted Options exercisable at $0.12 each on or before 5 October 2026. Netwealth Investments Limited - member of the managed super fund • 275,874 fully paid ordinary shares. • 16,228 Unlisted Options exercisable at $0.12 each on or before 5 October 2026. Cherylyn Vickery -beneficiary of the Trust • 2,000,000 Unlisted Options exercisable at $0.114 on or before 13 November 2024.

Nature of change

Nature of change Participation in the non-renounceable pro rata entitlement offer to Example: on-market trade, off-market trade, eligible shareholders announced on 4 September 2023, which exercise of options, issue of securities under dividend reinvestment plan, participation in closed on 28 September 2023. buy-back

Part 2 – Change of director’s interests in contracts – N/A

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

thispart.
Detail of contract	N/A
Nature of interest	N/A
Name of registered holder (if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	N/A
Interest after change	N/A

Part 3 –[+] Closed period

art 3 –+Closed period
Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A